nadifloxacin has been researched along with Staphylococcal Skin Infections in 5 studies
nadifloxacin: (R)-isomer does not induce chromosomal aberrations, unlike (S)-isomer; structure given in first source
Staphylococcal Skin Infections: Infections to the skin caused by bacteria of the genus STAPHYLOCOCCUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nadifloxacin is a potent, broad-spectrum, quinolone agent approved for topical use in acne vulgaris and skin infections in Japan." | 4.83 | Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771. ( Appelbaum, PC; Jacobs, MR, 2006) |
| "Nadifloxacin (NDFX) is a fluoroquinolone antibiotic developed by Otsuka Pharmaceutical Co." | 1.33 | [Antibacterial activity of nadifloxacin against Staphylococcus and Propionibacterium isolated from patients with dermatological infections]. ( Hasegawa, M; Kobayashi, I; Matsuzaki, K; Omika, K; Sato, Y, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanayama, S | 1 |
| Ikeda, F | 1 |
| Okamoto, K | 1 |
| Nakajima, A | 1 |
| Matsumoto, T | 1 |
| Ishii, R | 1 |
| Amano, A | 1 |
| Matsuzaki, K | 2 |
| Matsumoto, S | 1 |
| Jacobs, MR | 1 |
| Appelbaum, PC | 1 |
| Omika, K | 1 |
| Hasegawa, M | 1 |
| Sato, Y | 1 |
| Kobayashi, I | 1 |
| Nishijima, S | 1 |
| Namura, S | 1 |
| Akamatsu, H | 1 |
| Kawai, S | 1 |
| Asada, Y | 1 |
| Kawabata, S | 1 |
| Fujita, M | 1 |
| Yamakawa, T | 1 |
| Mitsuyama, J | 1 |
| Hayashi, K | 1 |
1 review available for nadifloxacin and Staphylococcal Skin Infections
| Article | Year |
|---|---|
Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Animals; Anti-Infective Agents; Clinical | 2006 |
4 other studies available for nadifloxacin and Staphylococcal Skin Infections
| Article | Year |
|---|---|
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Topics: Administration, Cutaneous; Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Child; Female; | 2016 |
[Antibacterial activity of nadifloxacin against Staphylococcus and Propionibacterium isolated from patients with dermatological infections].
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Methicillin Resistance; Propionibacterium; Quinoliz | 2006 |
In vitro activity of nadifloxacin against both methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus from patients with skin infections.
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Methicillin Resistance; Quinolizines; Staphylococca | 1995 |
In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
Topics: Animals; Anti-Infective Agents; Clindamycin; Colony Count, Microbial; DNA Topoisomerase IV; Drug Res | 2002 |